Literature DB >> 9310317

A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1.

J R McWhirter1, M Goulding, J A Weiner, J Chun, C Murre.   

Abstract

Pbx1 is a homeodomain transcription factor that has the ability to form heterodimers with homeodomain proteins encoded by the homeotic selector (Hox) gene complexes and increase their DNA-binding affinity and specificity. A current hypothesis proposes that interactions with Pbx1 are necessary for Hox proteins to regulate downstream target genes that in turn control growth, differentiation and morphogenesis during development. In pre B cell leukemias containing the t(1;19) chromosome translocation, Pbx1 is converted into a strong transactivator by fusion to the activation domain of the bHLH transcription factor E2A. The E2A-Pbx1 fusion protein should therefore activate transcription of genes normally regulated by Pbx1. We have used the subtractive process of representational difference analysis to identify targets of E2A-Pbx1. We show that E2A-Pbx1 can directly activate transcription of a novel member of the fibroblast growth factor family of intercellular signalling molecules, FGF-15. The FGF-15 gene is expressed in a regionally restricted pattern in the developing nervous system, suggesting that FGF-15 may play an important role in regulating cell division and patterning within specific regions of the embryonic brain, spinal cord and sensory organs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310317     DOI: 10.1242/dev.124.17.3221

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  46 in total

1.  Gene expression profiles in normal and Otx2-/- early gastrulating mouse embryos.

Authors:  L Zakin; B Reversade; B Virlon; C Rusniok; P Glaser; J M Elalouf; P Brulet
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 3.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

Review 4.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

Review 5.  The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye.

Authors:  Kapil Bharti; Minh-Thanh T Nguyen; Susan Skuntz; Stefano Bertuzzi; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2006-10

Review 6.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

7.  FGF signaling is strictly required to maintain early telencephalic precursor cell survival.

Authors:  Hunki Paek; Grigoriy Gutin; Jean M Hébert
Journal:  Development       Date:  2009-07       Impact factor: 6.868

Review 8.  Bile Acids as Hormones: The FXR-FGF15/19 Pathway.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 9.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

10.  Genomic characterisation of a Fgf-regulated gradient-based neocortical protomap.

Authors:  Stephen N Sansom; Jean M Hébert; Uruporn Thammongkol; James Smith; Grace Nisbet; M Azim Surani; Susan K McConnell; Frederick J Livesey
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.